July 31, 2020
By Ethel Makila, Associate Director, Advocacy Policy and Communications, IAVI
Features
Thumbi Ndung'u, Ph.D., provides a view of current strategies for HIV vaccine and cure design
June 22, 2020
IAVI recognizes the government of Japan’s continued commitment to HIV vaccine research and most recently COVID-19 vaccine research and applauds ...
June 15, 2020
Findings offer promise for accelerated development of antibody-based prevention and treatment for COVID-19
Summarizing the impact of COVID-19 on ongoing HIV and TB prevention research
June 4, 2020
IAVI's response to the role that racism and systematic oppression play in the daily lives of black people
Mark Feinberg and Swati Gupta introduce viewers to the COVID-19 vaccine candidate, which uses the same technology as Merck’s Ebola ...
Seventh edition of webinar series tackles community engagement in a time of social distancing.
May 18, 2020
IAVI welcomes evidence of cabotegravir’s safety and efficacy in cisgender men and transgender women who have sex with men.
March 30, 2020
IAVI's response to the COVID-19 pandemic
March 19, 2020
On this World TB Day, IAVI calls for support for TB prevention. #ItsTimeToEndTB
Show More
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
